Dyne Therapeutics Inc. (DYN)
12.11
-0.25 (-2.02%)
At close: Mar 13, 2025, 3:04 PM
Dyne Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
Cash & Equivalents | 435.45M | 121.63M | 172.15M | 200.82M | 300.85M | 14.63M | 8.12M | 365M | 1.78B | 505M | 1.87B | 843M | 348M | 396M | 291M | 471M | 693M | 328M |
Short-Term Investments | 206.82M | 1.47M | 83.86M | 175.75M | 44.46M | n/a | n/a | 32M | 130M | 100M | 78M | 25M | 13M | 69M | 106M | 78M | 87M | 104M |
Long-Term Investments | n/a | n/a | 2.32M | 2.31M | 2.3M | n/a | n/a | 26M | 16M | 18M | 2M | 11M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.94M | 2.31M | 9.58M | n/a | 3.77M | 191K | 0.00 | -31M | 1.67B | 330M | 5.25B | 72M | 181M | 116M | 1.34B | -536M | -329M | -66M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 513M | 386M | 402M | 270M | 420M | 108M | 6M | 230M | 212M | 340M | 426M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 445M | 445M | 597M | 208M | 181M | 101M | 57M | 121M | 141M | 184M | 199M |
Other Current Assets | 17.01M | 6.28M | 9.58M | 11.64M | 7.55M | 254K | 34K | 169M | 250M | 341M | 248M | 216M | 473M | 144M | 1.5B | 1.14B | 1.5B | 606M |
Total Current Assets | 659.28M | 129.38M | 256.01M | 382.39M | 345.31M | 14.76M | 8.16M | 1.52B | 2.99B | 1.95B | 2.67B | 1.69B | 1.04B | 672M | 2.24B | 2.04B | 2.8B | 1.66B |
Property-Plant & Equipment | 30.01M | 33.39M | 38.41M | 40.96M | 1.95M | 1.49M | 110K | 8.88B | 7.12B | 8.35B | 3.25B | 3.31B | 3.02B | 3.33B | 6.27B | 9.07B | 10.87B | 10.69B |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 797M | 837M | 899M | 27M | 108M | 271M | n/a | 141M | 380M | 870M | 935M |
Total Long-Term Assets | 31.95M | 35.71M | 50.31M | 43.27M | 8.02M | 1.68M | 110K | 10.25B | 10.07B | 9.59B | 8.56B | 3.61B | 3.49B | 3.46B | 7.77B | 8.91B | 11.41B | 11.56B |
Total Assets | 691.23M | 165.08M | 306.32M | 425.66M | 353.33M | 16.44M | 8.27M | 11.77B | 13.05B | 11.54B | 11.23B | 5.29B | 4.54B | 4.13B | 10.01B | 10.95B | 14.21B | 13.22B |
Account Payables | 6.56M | 22.94M | 5.26M | 4.03M | 3.44M | 1.26M | 518K | 367M | 332M | 292M | 216M | 329M | 112M | 15M | 134M | 181M | 303M | 292M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7M | 5M | 29M | 20M | 100M | 95M | 5M | 12M | 6M | 6M | 45M |
Short-Term Debt | 4.85M | 4.72M | 9.22M | 7.79M | n/a | n/a | n/a | 105M | 201M | 83M | 31M | 13M | 29M | 4M | 148M | 807M | 64M | 51M |
Other Current Liabilities | 30.85M | 23.44M | 13.61M | 16.91M | 7.53M | 1.1M | 193K | 506M | 375M | 405M | 410M | 5M | 110M | 135M | 1.27B | 853M | 1.33B | 611M |
Total Current Liabilities | 42.26M | 51.09M | 28.09M | 28.72M | 10.97M | 2.36M | 711K | 1.05B | 916M | 812M | 681M | 721M | 347M | 159M | 1.56B | 1.85B | 1.7B | 999M |
Long-Term Debt | 19.14M | 22.7M | 51.75M | 57.49M | n/a | n/a | 3.38M | 8.33B | 8.78B | 7.21B | 7.08B | 1.98B | 1.39B | 584M | 4.43B | 807M | 64M | 51M |
Other Long-Term Liabilities | n/a | n/a | -25.87M | -28.74M | n/a | 42K | 9.06M | 146M | 170M | 183M | 217M | 178M | 257M | 145M | 336M | 359M | 500M | 388M |
Total Long-Term Liabilities | 19.14M | 22.7M | 25.87M | 28.74M | n/a | 42K | 12.44M | 8.48B | 8.95B | 7.42B | 7.31B | 2.26B | 1.74B | 734M | 5.4B | 1.17B | 564M | 439M |
Total Liabilities | 61.4M | 73.79M | 53.96M | 57.47M | 10.97M | 2.4M | 13.15M | 9.87B | 11.01B | 8.62B | 8.21B | 3.08B | 2.03B | 3.02B | 7.27B | 7.97B | 9.73B | 8.69B |
Total Debt | 23.99M | 27.41M | 30.48M | 32.64M | n/a | n/a | 3.38M | 8.43B | 8.98B | 7.29B | 7.11B | 1.99B | 1.42B | 588M | 4.57B | 1.61B | 128M | 102M |
Common Stock | 10K | 6K | 6K | 6K | 5K | 1K | 1K | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 6M | 5M | 5M |
Retained Earnings | -949.93M | -632.51M | -396.57M | -228.47M | -79.18M | -19.75M | -4.89M | -1.85B | -1.93B | -686M | -736M | -463M | -107M | -4.84B | -3.2B | n/a | n/a | n/a |
Comprehensive Income | 6K | n/a | -571K | -269K | -27K | -0.00 | -24K | 32M | 21M | 19M | 20M | 58M | 11M | -53M | -53M | -150M | -215M | -25M |
Shareholders Equity | 629.84M | 91.29M | 252.36M | 368.2M | 342.37M | 14.04M | -4.88M | 1.9B | 2.04B | 2.92B | 3.02B | 2.21B | 2.5B | 1.11B | 2.75B | 2.9B | 4.51B | 4.51B |
Total Investments | 206.82M | 1.47M | 83.86M | 175.75M | 44.46M | n/a | n/a | 58M | 146M | 118M | 80M | 36M | 13M | 69M | 106M | 78M | 87M | 104M |